You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 9, September 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Heat Shock Enhances the Susceptibility of Tumor Cells to Lysis by Lymphokine-Activated Killer Cells

Shigeharu Fujieda, MD; Ichiro Noda, MD; Hitoshi Saito, MD; Takashi Hoshino, MD; Masato Yagita, MD

Arch Otolaryngol Head Neck Surg. 1995;121(9):1009-1014.


Abstract

Objective
To determine whether heat-treated thyroid cancer cells augment the susceptibility of target cells to lysis by autologous lymphokine-activated killer cells.

Design
Peripheral blood lymphocytes from patients with thyroid cancer were incubated with recombinant interleukin 2 (100 U/mL) for 7 days, and thyroid cancer cells obtained from surgical specimens were heated at 44°C for 20 minutes and incubated at 37°C for 18 hours before performing the radioactive chromium Cr 51 release assay.

Results
The susceptibility of heat-treated thyroid cancer cells to lysis by autologous and allogeneic lymphokine-activated killer cells was significantly greater than that of untreated tumor cells. The mechanism of enhanced susceptibility was unclear. However, the effect depended on de novo protein synthesis, because inhibition of RNA synthesis by dactinomycin completely abolished the heat-enhanced susceptibility of tumor cells.

Conclusion
Immunotherapy combined with hyperthermia may be useful in management of thyroid cancer.

(Arch Otolaryngol Head Neck Surg. 1995;121:1009-1014)



Author Affiliations

From the Department of Oto-Rhino-Laryngology, Fuki (Japan) Medical School (Drs Fujieda, Noda, and Saito); the Division of Allergy and Rheumatic Disease, Institute of Medical Science, St Marianna University, Kawasaki, Japan (Dr Hoshino); and the Department of Internal Medicine, Kitano Hospital, Tazuke-Kofukai Medical Research Institute, Osaka, Japan (Dr Yagita).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hsp70 promotes TNF-mediated apoptosis by binding IKK{gamma} and impairing NF-{kappa}B survival signaling
Ran et al.
Genes Dev. 2004;18:1466-1481.
ABSTRACT | FULL TEXT  

Heat Shock Protein 70 Is Able to Prevent Heat Shock-Induced Resistance of Target Cells to CTL
Dressel et al.
J. Immunol. 2000;164:2362-2371.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.